reyataz

Generic: atazanavir

Labeler: e.r. squibb & sons, l.l.c.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name reyataz
Generic Name atazanavir
Labeler e.r. squibb & sons, l.l.c.
Dosage Form CAPSULE, GELATIN COATED
Routes
ORAL
Active Ingredients

atazanavir sulfate 200 mg/1

Manufacturer
E.R. Squibb & Sons, L.L.C.

Identifiers & Regulatory

Product NDC 0003-3631
Product ID 0003-3631_510c2d51-4943-401c-a008-ea22f61c6938
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021567
Listing Expiration 2026-12-31
Marketing Start 2003-06-24

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] hiv protease inhibitors [moa] protease inhibitor [epc] udp glucuronosyltransferases inhibitors [moa] ugt1a1 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00033631
Hyphenated Format 0003-3631

Supplemental Identifiers

RxCUI
402093 402094 402246 402247 664741 664743 1598985 1598989
UPC
0300033624120 0300033622126
UNII
4MT4VIE29P

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name reyataz (source: ndc)
Generic Name atazanavir (source: ndc)
Application Number NDA021567 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3631-12)
source: ndc

Packages (1)

0003-3631-12 60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3631-12)

Ingredients (1)

atazanavir sulfate (200 mg/1)

Linked Drug Pages (1)

REYATAZ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "510c2d51-4943-401c-a008-ea22f61c6938", "openfda": {"upc": ["0300033624120", "0300033622126"], "unii": ["4MT4VIE29P"], "rxcui": ["402093", "402094", "402246", "402247", "664741", "664743", "1598985", "1598989"], "spl_set_id": ["165cff62-b284-4a27-a65d-9ec8a5bfcdd8"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3631-12)", "package_ndc": "0003-3631-12", "marketing_start_date": "20030624"}], "brand_name": "REYATAZ", "product_id": "0003-3631_510c2d51-4943-401c-a008-ea22f61c6938", "dosage_form": "CAPSULE, GELATIN COATED", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "0003-3631", "generic_name": "ATAZANAVIR", "labeler_name": "E.R. Squibb & Sons, L.L.C.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "REYATAZ", "active_ingredients": [{"name": "ATAZANAVIR SULFATE", "strength": "200 mg/1"}], "application_number": "NDA021567", "marketing_category": "NDA", "marketing_start_date": "20030624", "listing_expiration_date": "20261231"}